The interplay of HIV and autophagy in early infection

R Cabrera-Rodríguez, S Pérez-Yanes… - Frontiers in …, 2021 - frontiersin.org
HIV/AIDS is still a global threat despite the notable efforts made by the scientific and health
communities to understand viral infection, to design new drugs or to improve existing ones …

Structural biology of HIV integrase strand transfer inhibitors

IK Jóźwik, DO Passos, D Lyumkis - Trends in pharmacological sciences, 2020 - cell.com
Integrase (IN) strand transfer inhibitors (INSTIs) are recent compounds in the antiretroviral
arsenal used against HIV. INSTIs work by blocking retroviral integration; an essential step in …

Liver fibrosis during antiretroviral treatment in HIV-infected individuals. Truth or tale?

AD Bakasis, T Androutsakos - Cells, 2021 - mdpi.com
After the introduction of antiretroviral treatment (ART) back in 1996, the lifespan of people
living with HIV (PLWH) has been substantially increased, while the major causes of …

[HTML][HTML] Antiviral classification

G Li, X Jing, P Zhang, E De Clercq - Encyclopedia of Virology, 2021 - ncbi.nlm.nih.gov
Over the past 60 years, more than 100 antiviral drugs or their combinations have been
approved for clinical use. Antiviral drugs can be classified according to their chemical nature …

Current computational approaches for the development of anti-HIV inhibitors: an overview

U Panwar, I Chandra, C Selvaraj… - Current pharmaceutical …, 2019 - ingentaconnect.com
Background: Today, HIV-1 infection has become an extensive problem to public health and
a greater challenge to all working researchers throughout the world. Since the beginning of …

[HTML][HTML] Conformational flexibility of the conserved hydrophobic pocket of HIV-1 gp41. Implications for the discovery of small-molecule fusion inhibitors

M Cano-Muñoz, S Jurado, B Morel… - International Journal of …, 2021 - Elsevier
During HIV-1 infection, the envelope glycoprotein subunit gp41 folds into a six-helix bundle
structure (6HB) formed by the interaction between its N-terminal (NHR) and C-terminal …

CCR5 promoter polymorphism− 2459G> A: Forgotten or ignored?

RK Mehlotra - Cells, 2019 - mdpi.com
CC chemokine receptor 5 (CCR5) polymorphisms, particularly a 32-base pair deletion (∆ 32)
in the open reading frame and− 2459G> A in the promoter, are well known for their …

Analysis of HIV latent infection model with multiple infection stages and different drug classes

A Alshorman, N Al-Hosainat… - Journal of Biological …, 2022 - Taylor & Francis
Latently infected CD 4+ T cells represent one of the major obstacles to HIV eradication even
after receiving prolonged highly active anti-retroviral therapy (HAART). Long-term use of …

[HTML][HTML] Identification of human immunodeficiency virus-1 E protein-targeting lead compounds by pharmacophore based screening

MM Almehmadi, AA Shafie, M Allahyani… - Saudi Medical …, 2022 - ncbi.nlm.nih.gov
Objectives: To identify potential compounds by seeking the knowledge of molecular
interactions between human immunodeficiency virus (HIV) glycoprotein (gp) 120 protein and …

Novel 2-alkylthio-1-benzylimidazole-5-carboxylic Acid Derivatives Targeting Gp41: Design, Synthesis, and In Vitro Anti-HIV Activity Evaluation

T Mostashari-Rad, S Claes, D Schols… - Current HIV …, 2022 - ingentaconnect.com
Background: Although current available medications have increased the quality of life in HIV-
infected patients, there are still some shortcomings in HIV treatment arising from viral …